TP53 and ovarian carcinoma: Together with transcriptomic data, the results support a role for SNX1 as a negative regulator of ovarian cancer cell growth, potentially through modulation of cell cycle progression, and indicate that this function is conserved in a p53-mutant HGSOC background.